Literature DB >> 21607857

Quantification of GPCR mRNA using real-time RT-PCR.

Trond Brattelid1, Finn Olav Levy.   

Abstract

Characterisation of G-protein-coupled receptor (GPCR) mRNA expression under normal, different pharmacological and pathological conditions in experimental animal models and human tissue biopsies by quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR) is a valuable approach to understand the regulation of GPCR expression. RT-qPCR is specific and sensitive with a broad dynamic range, which allows precise quantification of mRNA species of interest. In addition to measuring the relative levels of mRNA in a tissue or changes in expression levels between groups of genes of interest, RT-qPCR is also used to identify splice variants and single nucleotide polymorphisms (SNPs) of GPCRs. Even though RT-qPCR has become the standard method for quantification of gene expression, RT-qPCR is sensitive to RNA quality, assay design, normalisation approach and data analysis. This protocol is meant as a guide to RT-qPCR methodology with references to the best standard methods available at present.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607857     DOI: 10.1007/978-1-61779-126-0_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Non-traditional roles of G protein-coupled receptors in basic cell biology.

Authors:  Xin Zhang; Ulrike S Eggert
Journal:  Mol Biosyst       Date:  2013-04-05

2.  G protein-coupled receptors participate in cytokinesis.

Authors:  Xin Zhang; Anne V Bedigian; Wenchao Wang; Ulrike S Eggert
Journal:  Cytoskeleton (Hoboken)       Date:  2012-08-28

3.  The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; Lise R Moltzau; Silje V S Bekkevold; Dagny L Sandnes; Jon Arne K Birkeland; Tor Skomedal; Jan-Bjørn Osnes; Ivar Sjaastad; Finn Olav Levy
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.